Deprescribing: An umbrella review

This umbrella review examined systematic reviews of deprescribing studies by characteristics of intervention, population, medicine, and setting. Clinical and humanistic outcomes, barriers and facilitators, and tools for deprescribing are presented. The Medline database was used. The search was limit...

Full description

Saved in:
Bibliographic Details
Published in:Acta pharmaceutica (Zagreb, Croatia) Croatia), 2024-06, Vol.74 (2), p.249-267
Main Authors: Japelj, Nuša, Horvat, Nejc, Knez, Lea, Kos, Mitja
Format: Article
Language:English
Subjects:
Clinical trials
deprescription
Deprescriptions
drug discontinuation
drug tapering
drug withdrawal
Drug-Related Side Effects and Adverse Reactions - prevention & control
Drugs
Humans
Inappropriate Prescribing - prevention & control
Intervention
Optimization
Patients
Polypharmacy
Systematic Reviews as Topic
umbrella review
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c405t-d09e5dc07ef595a70dd5342807ca203dc59a6b28157cf4f7fd61b73782ea1c2c3
container_end_page 267
container_issue 2
container_start_page 249
container_title Acta pharmaceutica (Zagreb, Croatia)
container_volume 74
creator Japelj, Nuša
Horvat, Nejc
Knez, Lea
Kos, Mitja
description This umbrella review examined systematic reviews of deprescribing studies by characteristics of intervention, population, medicine, and setting. Clinical and humanistic outcomes, barriers and facilitators, and tools for deprescribing are presented. The Medline database was used. The search was limited to systematic reviews and meta-analyses published in English up to April 2022. Reviews reporting deprescribing were included, while those where depre-scribing was not planned and supervised by a healthcare professional were excluded. A total of 94 systematic reviews (23 meta--analyses) were included. Most explored clinical or humanistic outcomes (70/94, 74 %); less explored attitudes, facilitators, or barriers to deprescribing (17/94, 18 %); few focused on tools (8/94, 8.5 %). Reviews assessing clinical or humanistic outcomes were divided into two groups: reviews with (39/70, 56 %; 16 reviewing specific deprescribing interventions and 23 broad medication optimisation interventions), and reviews with (31/70, 44 %). Deprescribing was feasible and resulted in a reduction of inappropriate medications in reviews with . Complex broad medication optimisation interventions were shown to reduce hospitalisation, falls, and mortality rates. In reviews of a higher frequency of adverse drug withdrawal events underscores the importance of prioritizing patient safety and exercising caution when stopping medicines, particularly in patients with clear and appropriate indications.
doi_str_mv 10.2478/acph-2024-0011
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_20019d83fe2c473a9dbafd92d7620c65</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_20019d83fe2c473a9dbafd92d7620c65</doaj_id><sourcerecordid>3063457857</sourcerecordid><originalsourceid>FETCH-LOGICAL-c405t-d09e5dc07ef595a70dd5342807ca203dc59a6b28157cf4f7fd61b73782ea1c2c3</originalsourceid><addsrcrecordid>eNptkUtP4zAUhS3EiEdhyxIVsWETuH7FDmKDeMwgIbGBteXYNyUlbYrdUPHvx5lAZxix8tHV53Mfh5ADCqdMKH1m3eI5Y8BEBkDpBtmhWuRZIaXe_Edvk90YpwBCKc22yDbXmkoGdIccXeMiYHShLuv55Hx8OR93szJg09hxwLcaV3vkR2WbiPsf74g83d48Xv3K7h9-3l1d3mdOgFxmHgqU3oHCShbSKvBecsE0KGcZcO9kYfOSpb7KVaJSlc9pqXiaBy11zPERuRt8fWunZhHqmQ3vprW1-VNow8TYsKxdg4alXQuveYXMCcVt4Utb-YJ5lTNwuUxe2eD1HJx9-WI2VGJwmKThlHOqE38y8IvQvnYYl2ZWR9cfYY5tFw2HnAuptFQJPf4PnbZdmKfL9BSDXCspEnU6UC60MQas1jNQMH1wpg_O9MGZPrj04fDDtitn6Nf4Z1IJuBiAlW2WGDxOQveexN_23zsrwZgo-G8vfKTp</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3062068754</pqid></control><display><type>article</type><title>Deprescribing: An umbrella review</title><source>Publicly Available Content Database</source><creator>Japelj, Nuša ; Horvat, Nejc ; Knez, Lea ; Kos, Mitja</creator><creatorcontrib>Japelj, Nuša ; Horvat, Nejc ; Knez, Lea ; Kos, Mitja</creatorcontrib><description>This umbrella review examined systematic reviews of deprescribing studies by characteristics of intervention, population, medicine, and setting. Clinical and humanistic outcomes, barriers and facilitators, and tools for deprescribing are presented. The Medline database was used. The search was limited to systematic reviews and meta-analyses published in English up to April 2022. Reviews reporting deprescribing were included, while those where depre-scribing was not planned and supervised by a healthcare professional were excluded. A total of 94 systematic reviews (23 meta--analyses) were included. Most explored clinical or humanistic outcomes (70/94, 74 %); less explored attitudes, facilitators, or barriers to deprescribing (17/94, 18 %); few focused on tools (8/94, 8.5 %). Reviews assessing clinical or humanistic outcomes were divided into two groups: reviews with (39/70, 56 %; 16 reviewing specific deprescribing interventions and 23 broad medication optimisation interventions), and reviews with (31/70, 44 %). Deprescribing was feasible and resulted in a reduction of inappropriate medications in reviews with . Complex broad medication optimisation interventions were shown to reduce hospitalisation, falls, and mortality rates. In reviews of a higher frequency of adverse drug withdrawal events underscores the importance of prioritizing patient safety and exercising caution when stopping medicines, particularly in patients with clear and appropriate indications.</description><identifier>ISSN: 1846-9558</identifier><identifier>ISSN: 1330-0075</identifier><identifier>EISSN: 1846-9558</identifier><identifier>DOI: 10.2478/acph-2024-0011</identifier><identifier>PMID: 38815201</identifier><identifier>CODEN: ACPHEE</identifier><language>eng</language><publisher>Poland: Sciendo</publisher><subject>Clinical trials ; deprescription ; Deprescriptions ; drug discontinuation ; drug tapering ; drug withdrawal ; Drug-Related Side Effects and Adverse Reactions - prevention &amp; control ; Drugs ; Humans ; Inappropriate Prescribing - prevention &amp; control ; Intervention ; Optimization ; Patients ; Polypharmacy ; Systematic Reviews as Topic ; umbrella review</subject><ispartof>Acta pharmaceutica (Zagreb, Croatia), 2024-06, Vol.74 (2), p.249-267</ispartof><rights>2024 Nuša Japelj et al., published by Sciendo.</rights><rights>2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/3.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c405t-d09e5dc07ef595a70dd5342807ca203dc59a6b28157cf4f7fd61b73782ea1c2c3</cites><orcidid>0000-0002-7743-2827 ; 0000-0002-6801-6450 ; 0000-0002-6340-9693 ; 0000-0001-8460-276X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/3062068754?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,777,781,882,25734,27905,27906,36993,36994,44571</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38815201$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Japelj, Nuša</creatorcontrib><creatorcontrib>Horvat, Nejc</creatorcontrib><creatorcontrib>Knez, Lea</creatorcontrib><creatorcontrib>Kos, Mitja</creatorcontrib><title>Deprescribing: An umbrella review</title><title>Acta pharmaceutica (Zagreb, Croatia)</title><addtitle>Acta Pharm</addtitle><description>This umbrella review examined systematic reviews of deprescribing studies by characteristics of intervention, population, medicine, and setting. Clinical and humanistic outcomes, barriers and facilitators, and tools for deprescribing are presented. The Medline database was used. The search was limited to systematic reviews and meta-analyses published in English up to April 2022. Reviews reporting deprescribing were included, while those where depre-scribing was not planned and supervised by a healthcare professional were excluded. A total of 94 systematic reviews (23 meta--analyses) were included. Most explored clinical or humanistic outcomes (70/94, 74 %); less explored attitudes, facilitators, or barriers to deprescribing (17/94, 18 %); few focused on tools (8/94, 8.5 %). Reviews assessing clinical or humanistic outcomes were divided into two groups: reviews with (39/70, 56 %; 16 reviewing specific deprescribing interventions and 23 broad medication optimisation interventions), and reviews with (31/70, 44 %). Deprescribing was feasible and resulted in a reduction of inappropriate medications in reviews with . Complex broad medication optimisation interventions were shown to reduce hospitalisation, falls, and mortality rates. In reviews of a higher frequency of adverse drug withdrawal events underscores the importance of prioritizing patient safety and exercising caution when stopping medicines, particularly in patients with clear and appropriate indications.</description><subject>Clinical trials</subject><subject>deprescription</subject><subject>Deprescriptions</subject><subject>drug discontinuation</subject><subject>drug tapering</subject><subject>drug withdrawal</subject><subject>Drug-Related Side Effects and Adverse Reactions - prevention &amp; control</subject><subject>Drugs</subject><subject>Humans</subject><subject>Inappropriate Prescribing - prevention &amp; control</subject><subject>Intervention</subject><subject>Optimization</subject><subject>Patients</subject><subject>Polypharmacy</subject><subject>Systematic Reviews as Topic</subject><subject>umbrella review</subject><issn>1846-9558</issn><issn>1330-0075</issn><issn>1846-9558</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkUtP4zAUhS3EiEdhyxIVsWETuH7FDmKDeMwgIbGBteXYNyUlbYrdUPHvx5lAZxix8tHV53Mfh5ADCqdMKH1m3eI5Y8BEBkDpBtmhWuRZIaXe_Edvk90YpwBCKc22yDbXmkoGdIccXeMiYHShLuv55Hx8OR93szJg09hxwLcaV3vkR2WbiPsf74g83d48Xv3K7h9-3l1d3mdOgFxmHgqU3oHCShbSKvBecsE0KGcZcO9kYfOSpb7KVaJSlc9pqXiaBy11zPERuRt8fWunZhHqmQ3vprW1-VNow8TYsKxdg4alXQuveYXMCcVt4Utb-YJ5lTNwuUxe2eD1HJx9-WI2VGJwmKThlHOqE38y8IvQvnYYl2ZWR9cfYY5tFw2HnAuptFQJPf4PnbZdmKfL9BSDXCspEnU6UC60MQas1jNQMH1wpg_O9MGZPrj04fDDtitn6Nf4Z1IJuBiAlW2WGDxOQveexN_23zsrwZgo-G8vfKTp</recordid><startdate>20240601</startdate><enddate>20240601</enddate><creator>Japelj, Nuša</creator><creator>Horvat, Nejc</creator><creator>Knez, Lea</creator><creator>Kos, Mitja</creator><general>Sciendo</general><general>De Gruyter Poland</general><general>Hrvatsko farmaceutsko društvo</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BYOGL</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>VP8</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-7743-2827</orcidid><orcidid>https://orcid.org/0000-0002-6801-6450</orcidid><orcidid>https://orcid.org/0000-0002-6340-9693</orcidid><orcidid>https://orcid.org/0000-0001-8460-276X</orcidid></search><sort><creationdate>20240601</creationdate><title>Deprescribing: An umbrella review</title><author>Japelj, Nuša ; Horvat, Nejc ; Knez, Lea ; Kos, Mitja</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c405t-d09e5dc07ef595a70dd5342807ca203dc59a6b28157cf4f7fd61b73782ea1c2c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Clinical trials</topic><topic>deprescription</topic><topic>Deprescriptions</topic><topic>drug discontinuation</topic><topic>drug tapering</topic><topic>drug withdrawal</topic><topic>Drug-Related Side Effects and Adverse Reactions - prevention &amp; control</topic><topic>Drugs</topic><topic>Humans</topic><topic>Inappropriate Prescribing - prevention &amp; control</topic><topic>Intervention</topic><topic>Optimization</topic><topic>Patients</topic><topic>Polypharmacy</topic><topic>Systematic Reviews as Topic</topic><topic>umbrella review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Japelj, Nuša</creatorcontrib><creatorcontrib>Horvat, Nejc</creatorcontrib><creatorcontrib>Knez, Lea</creatorcontrib><creatorcontrib>Kos, Mitja</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>East Europe, Central Europe Database</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Hrcak: Portal of scientific journals of Croatia</collection><collection>Directory of Open Access Journals</collection><jtitle>Acta pharmaceutica (Zagreb, Croatia)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Japelj, Nuša</au><au>Horvat, Nejc</au><au>Knez, Lea</au><au>Kos, Mitja</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Deprescribing: An umbrella review</atitle><jtitle>Acta pharmaceutica (Zagreb, Croatia)</jtitle><addtitle>Acta Pharm</addtitle><date>2024-06-01</date><risdate>2024</risdate><volume>74</volume><issue>2</issue><spage>249</spage><epage>267</epage><pages>249-267</pages><issn>1846-9558</issn><issn>1330-0075</issn><eissn>1846-9558</eissn><coden>ACPHEE</coden><abstract>This umbrella review examined systematic reviews of deprescribing studies by characteristics of intervention, population, medicine, and setting. Clinical and humanistic outcomes, barriers and facilitators, and tools for deprescribing are presented. The Medline database was used. The search was limited to systematic reviews and meta-analyses published in English up to April 2022. Reviews reporting deprescribing were included, while those where depre-scribing was not planned and supervised by a healthcare professional were excluded. A total of 94 systematic reviews (23 meta--analyses) were included. Most explored clinical or humanistic outcomes (70/94, 74 %); less explored attitudes, facilitators, or barriers to deprescribing (17/94, 18 %); few focused on tools (8/94, 8.5 %). Reviews assessing clinical or humanistic outcomes were divided into two groups: reviews with (39/70, 56 %; 16 reviewing specific deprescribing interventions and 23 broad medication optimisation interventions), and reviews with (31/70, 44 %). Deprescribing was feasible and resulted in a reduction of inappropriate medications in reviews with . Complex broad medication optimisation interventions were shown to reduce hospitalisation, falls, and mortality rates. In reviews of a higher frequency of adverse drug withdrawal events underscores the importance of prioritizing patient safety and exercising caution when stopping medicines, particularly in patients with clear and appropriate indications.</abstract><cop>Poland</cop><pub>Sciendo</pub><pmid>38815201</pmid><doi>10.2478/acph-2024-0011</doi><tpages>19</tpages><orcidid>https://orcid.org/0000-0002-7743-2827</orcidid><orcidid>https://orcid.org/0000-0002-6801-6450</orcidid><orcidid>https://orcid.org/0000-0002-6340-9693</orcidid><orcidid>https://orcid.org/0000-0001-8460-276X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1846-9558
ispartof Acta pharmaceutica (Zagreb, Croatia), 2024-06, Vol.74 (2), p.249-267
issn 1846-9558
1330-0075
1846-9558
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_20019d83fe2c473a9dbafd92d7620c65
source Publicly Available Content Database
subjects Clinical trials
deprescription
Deprescriptions
drug discontinuation
drug tapering
drug withdrawal
Drug-Related Side Effects and Adverse Reactions - prevention & control
Drugs
Humans
Inappropriate Prescribing - prevention & control
Intervention
Optimization
Patients
Polypharmacy
Systematic Reviews as Topic
umbrella review
title Deprescribing: An umbrella review
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T18%3A26%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Deprescribing:%20An%20umbrella%20review&rft.jtitle=Acta%20pharmaceutica%20(Zagreb,%20Croatia)&rft.au=Japelj,%20Nu%C5%A1a&rft.date=2024-06-01&rft.volume=74&rft.issue=2&rft.spage=249&rft.epage=267&rft.pages=249-267&rft.issn=1846-9558&rft.eissn=1846-9558&rft.coden=ACPHEE&rft_id=info:doi/10.2478/acph-2024-0011&rft_dat=%3Cproquest_doaj_%3E3063457857%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c405t-d09e5dc07ef595a70dd5342807ca203dc59a6b28157cf4f7fd61b73782ea1c2c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3062068754&rft_id=info:pmid/38815201&rfr_iscdi=true